Janux Therapeutics: Potential JANX007 Comeback mCRPC And Initial JANX011 Data ↗Seeking Alpha · 2026-11-17
Bayer gains approval of Factor XIa inhibitor asundexian to reduce stroke risk ↗Seeking Alpha · 2026-11-10